Home
About Us
Subject
Browse
0
Sign In
Eculizumab
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Haemolytic uraemic syndrome associated with pancreatitis: report of four cases and review of the literature
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: a Meta-analysis of Randomized Control Trials
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
Article
Year: 2021
Pages: 19
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Case Report: A Rare Truncating Variant of the
CFHR5
Gene in IgA Nephropathy
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Concept confirmation of the Treatment Administration Satisfaction Questionnaire (TASQ) in rare paroxysmal nocturnal hemoglobinuria
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration
Article
Year: 2021
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger’s Disease
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies
Article
Year: 2021
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
Article
Year: 2020
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Current treatment in COVID-19 disease: a rapid review
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The use of eculizumab in
Capnocytophaga canimorsus
associated thrombotic microangiopathy: a case report
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome– a single center experience
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info